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Vuvuzela sound measurements
To the Editor: Our recent paper in the SAMJ1 reported the 
maximum output levels of a vuvuzela at various distances 
from the horn. In response to enquiries, we provide additional 
information on the method and results reported in the earlier 
paper.
One commercial vuvuzela was used in the recording of 
sound levels at 4 different positions: (i) at the ear of the person 
blowing the vuvuzela; (ii) at the bell end; (iii) 1 m from the 
bell end; and (iv) 2 m from the bell end. All measurements 
were made approximately 1.6 m from the ground, in an open-
air setting. Sound levels were measured twice at a single 
instance while the vuvuzela was being blown by one of the 
investigators. Measurements were made using a calibrated 
Type 1 Larson Davis SLM 824 sound level meter with a 2559 
normal sensitivity microphone fitted with a manufacturer-
supplied windscreen (WS001). Measurements were made using 
the fast response time option, which corresponds to a time 
constant of 0.125 s that is intended to approximate the time 
constant of human hearing.2
The initial report1 provided the maximum instantaneous 
A-weighted sound pressure level (Lmax Fast [dBA]) averaged 
for 2 recordings during single vuvuzela blasts at 4 distances 
from the bell of the vuvuzela. This method is in agreement 
with the recommendation by the World Health Organization2 
for measuring individual sound events. A-weighting was 
used for all measurements to compensate for the non-linear 
sensitivity of the human ear, which is differentially sensitive 
to sound across the frequency spectrum (least sensitive at 
very high and very low frequencies). A breakdown of the 
average intensities at individual frequencies across the 
frequency spectrum is provided in Table I. A characteristically 
flat frequency spectrum was evident between 250 and 8 000 
Hz. The average intensity difference between the individual 
frequency measurements (Table I) of the 2 recordings at each of 
the 4 respective distances from the bell of the vuvuzela was 0.6 
dB (±3.2 dB standard deviation).
These measures provide an indication of the sound levels 
and frequency spectrum of a typical vuvuzela. There are now 
numerous types of vuvuzela made by several manufacturers, 
which may all produce varying intensity and frequency 
outputs. In addition to these variables, individuals blowing 
a vuvuzela will produce varying intensities depending on 
their technique and the pressure exerted. Also, the sound level 
produced by multiple individuals simultaneously blowing 
vuvuzelas within a limited space cannot be predicted from 
these data.
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Pandemic flu (H1N1) 2009 and pregnancy
To the Editor: We welcome the recommendations by Schoub 
et al.1 and advertisements in local newspapers highlighting the 
importance of influenza vaccination (Cape Times 17 February 
2010), but are concerned that there is no unified strategy to 
ensure that all pregnant women are offered influenza vaccine 
and have access to antivirals should they develop symptoms of 
infection.
A striking feature of the pandemic H1N1 infection has been 
the predilection of severe disease in pregnant women. This 
is not surprising as pregnancy causes immunological and 
physiological changes which are likely to contribute to an 
increased susceptibility to influenza infection and an excessive 
risk of influenza-related morbidity and mortality.2 We have 
previously highlighted the problem of H1N1 in South Africa in 
pregnant women.3
Antivirals oseltamivir and zanamivir are effective against 
H1N1, and both may be used in pregnancy.2 Despite a lack of 
formal trials in pregnancy, both have been widely used in the 
second and third trimester without proven adverse effects on 
the mother or teratogenic effects on the unborn child. Their 
use is justified on the basis that the potential benefit to the 
mother outweighs any potential risk to the fetus.4 However, 
antiviral therapy must be initiated early to be effective, posing 
a considerable logistical challenge.5 Vaccination is the most 
important weapon in preventing influenza infection and its 
sequelae in pregnant women. Pregnant women have been 
prioritised for vaccination in industrialised countries during 
the 2009/2010 season. The inactivated influenza vaccine 
is void of harmful effects on maternal or neonatal health.6 
Since pandemic H1N1 vaccines are produced using the same 
manufacturing and licensing process as seasonal influenza 
Table I. Average vuvuzela intensity measurements across 
frequencies at 4 distinct distances from the bell end of the 
vuvuzela (dBA)
Frequency
       Intensity (dBA)
(Hz)         At ear          Bell opening           1 m               2 m
125              36      62             38  35
250              92   106             82  85
500            103   121           102                101
1 000            106   122           108                100
2 000            101   122           110                101
4 000              97   109           110                102
5 000              93   111           109                100
8 000              87   110           107  98
